Syndax Pharmaceuticals (SNDX) Other Accumulated Expenses (2015 - 2026)
Syndax Pharmaceuticals (SNDX) reported Other Accumulated Expenses of $1.96 million for Q3 2026, up 229.1% from $595,000 a year earlier and up 26.3% from the prior quarter.
Powered by 
Analysis
Syndax Pharmaceuticals (SNDX) Other Accumulated Expenses (2015 - 2026) Analysis & Trends
At the end of FY2025, Syndax Pharmaceuticals posted Other Accumulated Expenses of $721,000, up 71.3% from FY2024.
- Other Accumulated Expenses has a five-year compound annual growth rate of 6.4% (FY2020 to FY2025).
- By year, Other Accumulated Expenses came in at $421,000 in FY2024 (-52.6%), $888,000 in FY2023 (+47.0%), $604,000 in FY2022 (-64.5%) and $1.7 million in FY2021 (+222.2%).
- The Q3 2026 figure ranks as the highest quarterly Other Accumulated Expenses since Q3 2022.
- Year over year, Other Accumulated Expenses has now increased in each of the last six quarters, with growth averaging 104.9% over the last eight quarters.
- The high point for year-over-year Other Accumulated Expenses in five years was Q2 2022 (growth of 984.2%); the low point was Q2 2023 (a decline of 83.1%).
- Per Business Quant data, the three quarters before Q3 2026 came in at $1.55 million (Q2 2026), $1.27 million (Q1 2026) and $721,000 (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn |
| 10 | Syndax Pharmaceuticals | 854.00 Mn | -867.10 Mn | 69.30 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.96 Mn |
| Jun 30, 2026 | 1.55 Mn |
| Mar 31, 2026 | 1.27 Mn |
| Dec 31, 2025 | 721,000.00 |
| Sep 30, 2025 | 595,000.00 |
| Jun 30, 2025 | 618,000.00 |
| Mar 31, 2025 | 576,000.00 |
| Dec 31, 2024 | 421,000.00 |
| Sep 30, 2024 | 208,000.00 |
| Jun 30, 2024 | 220,000.00 |
| Mar 31, 2024 | 1.08 Mn |
| Dec 31, 2023 | 888,000.00 |
| Sep 30, 2023 | 768,000.00 |
| Jun 30, 2023 | 534,000.00 |
| Mar 31, 2023 | 703,000.00 |
| Dec 31, 2022 | 604,000.00 |
| Sep 30, 2022 | 3.19 Mn |
| Jun 30, 2022 | 3.17 Mn |
| Mar 31, 2022 | 1.89 Mn |
| Dec 31, 2021 | 1.70 Mn |
API Access
Syndax Pharmaceuticals Other Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "other-accumulated-expenses", "ticker": "SNDX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=other-accumulated-expenses&ticker=SNDX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();